NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that it will host its Healthcare Day on Wednesday, June 24, 2015 at the Dorchester Hotel in London, U.K.
ROTH’s Healthcare Day will give investors the opportunity to interact with senior management of a select group of Life Sciences companies focused in the Biotechnology, Medical Technologies and Specialty Pharmaceuticals sectors.
The event will allow for extensive interaction and on-on-one meetings with management teams, providing in-depth insights into each company.
ROTH biotechnology senior research analysts Joe Pantginis, Ph.D., Elemer Piros, Ph.D., Michael Higgins and Debjit Chattopadhyay, Ph.D., as well as Specialty Pharmaceuticals senior research analyst Scott Henry, CFA and Chris Lewis, Research Analyst – Medical Technologies will be available to discuss their perspectives regarding the companies attending and their views regarding the current healthcare market trends.
“The Life Sciences sector has experienced rapid and significant growth in the past several years with no signs of slowing down. This event is designed to provide investors with direct interactions to management teams of a select group of high quality companies from early to late stage development, through commercialization,” commented John W. Chambers, Vice Chairman and Head of Healthcare Investment Banking at ROTH. “With the expansion of the number of publicly traded companies via an active IPO market, investors have more companies to track. Our goal is to provide investors access to a select number of companies representing a broad range of market capitalizations as well as several newly minted public companies, and to enable investors to further understand their scientific approach, clinical achievements to date and upcoming milestones and catalysts. This event comprising exclusively one-on-one meetings will enable investors to gain direct insight into the key value drivers for this group of innovative companies.”
ROTH has built a leading Healthcare Investment Banking Group over the last several years and has raised approximately $9.7 billion in over 255 Healthcare transactions since 2010. *Past Performance is not indicative of future returns. (Source: ROTH Capital 06/08/2015)
The event is for institutional clients of ROTH and is by invitation only. For more information, please contact your ROTH sales representative at (949) 720-5700 or e-mail: conference@roth.com
Agenda and Events
Wednesday | June 24, 2014
8:00 am - 9:00 am | Morning Coffee
12:00
pm – 1:00 pm | Lunch
9:00 am - 5:00 pm | 1-on-1 / Small Group
Meetings
5:00 pm - 7:00 pm | Cocktail Reception
Venue:
The Dorchester
53 Park Lane, Mayfair
London,
W1K 1QA, UK
Tel: +44 (0) 20-7629-8888
Participating Companies
The following participating
companies are confirmed as of the date of this release:
| Bio Blast Pharma Ltd. | ORPN | |
| Biodel Inc. | BIOD | |
| BioLineRx, Ltd. | BLRX | |
| Cempra, Inc. | CEMP | |
| Conatus Pharmaceuticals Inc. | CNAT | |
| Cortendo AB (publ) | OTCNO:CORT | |
| CTI BioPharma Corp. | CTIC | |
| Evotec AG | EVT | |
| Galmed Pharmaceuticals Ltd. | GLMD | |
| IntelliPharmaCeutics International Inc. | IPCI | |
| IRadimed Corporation | IRMD | |
| Juniper Pharmaceuticals, Inc. | JNP | |
| Ligand Pharmaceuticals Incorporated | LGND | |
| MacroGenics, Inc. | MGNX | |
| Natus Medical Inc. | BABY | |
| NeuroDerm Ltd. | NDRM | |
| Oxford BioMedica PLC | LSE:OXB | |
| Pharming Group NV | PHARM | |
| RedHill Biopharma Ltd. | RDHL | |
| Second Sight Medical Products, Inc. | EYES | |
| Spark Therapeutics, Inc. | ONCE | |
| Synta Pharmaceuticals Corp. | SNTA | |
| TearLab Corporation | TEAR | |
| Titan Pharmaceuticals Inc. | TTNP | |
| Tonix Pharmaceuticals Holding Corp | TNXP | |
| Trinity Biotech plc | TRIB | |
| uniQure N.V. | QURE | |
| Vectura Group | VEC |
Event sponsors include Business Wire, Equisolve.Lowenstein Sandler and Vintage.
About Roth Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. and Hong Kong. For more information on ROTH, please visit www.roth.com.
